On the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool may help identify newborns at highest risk for developing serious RSV LRTI, according to new research.
On the heels of a shortage of nirsevimab for infant respiratory syncytial virus lower respiratory tract infection prevention, a new tool may help identify newborns at highest risk for developing serious RSV LRTI, according to new research.
More than half of RSV LRTIs are among healthy, term infants who are generally considered low risk. These infants are, in fact, at risk for requiring intensive care unit -level care, and some may die from their illness.
"Our objective was to develop a personalized tool for use in all newborns using readily available birth and postnatal data to predict risk of RSV LRTI requiring ICU admission, useful for prioritizing RSV prevention products with limited availability," said Principal Investigator Tina V. Hartert, MD, MPH, professor of medicine and pediatrics at Vanderbilt University Medical Center.
Cholesterol Asthma Medical Topics Personalized Medicine Heart Disease Wounds And Healing Down Syndrome
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
‘New energy, new era’: Texans unveiling new uniforms ahead of NFL DraftTexans to unveil four new uniforms April 23 at reveal party
Read more »
Texans unveil new uniforms, helmets: ‘New energy, new era’Texans roll out new uniforms
Read more »
Dua Lipa tries out new sound and new outlook with new album 'Radical Optimism'While promoting her third album 'Radical Optimism,' Dua Lipa visited a New York public high school with Drew Barrymore. Lipa discusses her career and the new sound of the album.
Read more »
Hands-on with Apple’s new iPad Pro: it’s thin, light, and OLEDApple’s new 2024 iPad Pro comes in 11- and 13-inch models, both with a new screen, new accessories, a new chip, and an impressively light and thin new design,.
Read more »
Did COVID-19 shutdowns weaken kids’ immune systems?Public-health experts exploring extent of restrictions’ role in elevated RSV infections after pandemic
Read more »
Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fallModerna beats estimates in Q1 2024, targets RSV vaccine launch in fall
Read more »